Advocacy Webpage Graphics Narrow Teach It 

Addiction is a complex medical disease that has become a public health emergency throughout the US. ASAM advocates for policies that grow the addiction medicine workforce by integrating addiction medicine into medical school and residency curricula, supporting training programs, and incentivizing clinicians to work in programs and practices that specialize in the treatment of substance use disorder.




What is Addiction?

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.

Click here to learn more




 
FOAM-header
 



Featured Public Policy Statements

_82007387_thinkstockphotos-515008423

E-Cigarettes

Learn more about ASAM's position on E-Cigarettes as a potential harm reduction strategy and for smoking cessation.

The Role of Recovery in Addiction Care

In ASAM’s definition, recovery from addiction is an active process of continual growth that addresses the biological, psychological, social and spiritual disturbances inherent in addiction.

Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Learn more about ASAM's policy recommendations on substance use, misuse, and SUDs during and following pregnancy.

Naloxone_2_(cropped)2

Use of Naloxone for the Prevention of Opioid Overdose Deaths

See ASAM's policy recommendations on Naloxone prescribing, training, and use.  







Strengthening the Substance Use Disorder Workforce Graphic




"When something is stigmatized nobody wants to bring it up,
so therefore people who need the help are less willing to come forward."

Corey Waller, MD, MS, FACEP, DFASAM
Member of ASAM's Legislative Advocacy Committee




Resources

11_PayForQuality - Copy


Learn more about the three medications currently approved by the FDA to treat opioid use disorder.

Updating map


How is the opioid overdose epidemic affecting your state?

cdc

Check out this CDC report and learn more about effective strategies to prevent opioid overdose in your community.

training

Learn more about the growing problem of controlled substance diversion from presentations made at the DEA Practitioner Diversion Awareness Conference

 
ecigarette2


Learn more about what the US Surgeon General has to say about e-cigarettes

 





ACCME 

Learn more about how ASAM is working to educate the next generation of addiction medicine professionals.





Related News

newspapers-3488857_1920B
  • July 23, 2019

    ASAM Board Member Testifies Before Congressional Opioid Task Force

    Dr. Margaret Jarvis, Board Member of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, Dr. Jarvis discussed the need for greater financial investment in demand-reduction interventions and emphasized the need for bold policy solutions to meet the scale of the opioid crisis.
  • May 9, 2019

    ASAM Praises Funding for Critical SUD Workforce Programs in FY 2020 House Labor-HHS Appropriations Bill

    ASAM praised the House Appropriations Committee for including full funding for two new critical substance use disorder (SUD) workforce programs in its FY 2020 Labor, Health and Human Services (HHS), Education, and Related Agencies appropriations bill.
  • May 8, 2019

    ASAM Applauds Introduction of Comprehensive Addiction Resources Emergency (CARE) Act of 2019

    ASAM commended Senator Elizabeth Warren, Representatives Elijah Cummings, and all original co-sponsors for introducing the CARE Act of 2019. Modeled on successful, bipartisan legislation passed in 1990 to address the HIV/AIDS epidemic, the CARE Act would authorize $100 billion in federal funding over the next decade to states, local governments, and other organizations and institutions to support substance use disorder treatment programs, improve training for addiction treatment professionals in communities across the US, and expand access to treatments that meet national standards and are proven to save lives.